![](https://endpts.com/wp-content/uploads/2021/04/Josh-Hoffman-Zymergen-tile-scaled.jpg)
Josh Hoffman, Zymergen CEO (Zymergen)
Zymergen's bid to disrupt a $3T industrial manufacturing market goes viral, earning a massive $500M IPO
Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here.
It’s not a story you hear every day …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.